Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,602.00
Bid: 12,600.00
Ask: 12,604.00
Change: 86.00 (0.69%)
Spread: 4.00 (0.032%)
Open: 12,566.00
High: 12,632.00
Low: 12,512.00
Prev. Close: 12,516.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates

Tue, 05th Jan 2021 12:00

By Tina Bellon

NEW YORK, Jan 5 (Reuters) - As millions of people await
their turn to get a COVID-19 vaccine that could be months away,
scammers online, in emails and on messaging apps are luring
victims with claims they can deliver shots within days for as
little as $150.

COVID-19 vaccine scams are on the rise, according to
European and U.S. government officials who are warning the
public of fraudsters out for money and personal data.

A Reuters search online, in dark web forums and on messaging
app Telegram found seven different offers for alleged COVID-19
vaccines.

Scams include emails promising entry to supposedly secret
lists for early vaccine access and robocallers impersonating
government agencies. Message boards on the so-called dark web
have added COVID-19 vaccines to more traditional illicit goods
for sale.

The U.S. FBI and Interpol, among others, have warned of
emerging pandemic-related fraud schemes, saying false cures and
vaccines advertised on fake websites could pose cyber threats
and a significant risk to peoples' health, or even lives.

Website domains containing the word vaccine in combination
with COVID-19 or coronavirus more than doubled since October to
roughly 2,500 in November, when the first legitimate vaccines
were nearing regulatory approval, according to cybersecurity
firm Recorded Future, which is tracking COVID-19 fraud online.

"So far a lot of these domains just appear to be
opportunistic registrations, but some are going to be used for
phishing attempts to have people click on (malicious) links,"
said Lindsay Kaye, director of operational outcomes at Recorded
Future.

Kaye said her team, which also scours the dark web, so far
has not come across any legitimate vaccine diverted from
healthcare facilities or national stockpiles.

The scams are preying on concerns about the far
slower-than-promised rollout of vaccines to protect against the
virus that has claimed more than 1.8 million lives worldwide so
far. Most people will likely have to wait well into the spring,
or even summer, to get their shot.

In the United States, only about 4.5 million people had
received their first shot as of Monday, the U.S. Centers for
Disease Control and Prevention reported. That is a fraction of
the 20 million who were supposed to have been vaccinated by the
end of 2020, according to earlier government forecasts.

VACCINES, GUNS AND MONEY

On dark web forum Agartha, fake COVID-19 vaccines were
offered next to cocaine, opioid medication, "super high quality
fake money," hand guns and gift cards. Posts showed stock photos
of vaccines and offered vials for $500 and $1,000, or the
equivalent in Bitcoin.

On another dark web site, a seller claiming to be from the
"Wuhan Institute of Science" offered COVID-19 vaccines in
exchange for a donation, and asked buyers to provide their
medical history.

On Telegram, several channels claimed to offer COVID-19
vaccines, accompanied by stock images. One user offered supposed
Moderna Inc vaccines for $180, and claimed the vaccine
from Pfizer Inc and BioNTech SE could be had
for $150 and AstraZeneca's for $110 per vial.

Asked how the vaccines would be shipped, the account creator
said they were transported in "regulated temperature packs" and
ice packs within a few days, or overnight for an additional
charge.

Actual COVID-19 vaccines, particularly the Pfizer/BioNTech
offering, must be temperature controlled to remain effective,
with drugmakers equipping shipments with temperature trackers to
ensure the cold chain. Vaccine shipments and distribution are
also tightly controlled by officials and will be administered
at no cost.

The United States has so far authorized two COVID-19
vaccines for emergency use - the ones from Pfizer/BioNTech and
Moderna. The European Union to date has authorized the
Pfizer/BioNTech vaccine and is expected to clear the Moderna
vaccine this week.

The UK has already authorized those two and just added the
vaccine developed by Oxford University with AstraZeneca.

Asked about vaccine scams, Pfizer said it had taken
meticulous steps to reduce the risk of counterfeiting and
tracked trends very carefully.

"Patients should never try to secure a vaccine online - no
legitimate vaccine is sold online - and only get vaccinated at
certified vaccination centers or by certified healthcare
providers," a Pfizer spokesman said in a statement.

Moderna referred a request for comment to the U.S.
Department of Health and Human Services (HHS), which did not
respond. AstraZeneca did not respond to a request for comment.

The HHS, FBI and U.S. Department of Justice have urged the
public to report any COVID-19 vaccine scams, including people
asking for out-of-pocket payments for the vaccine and online
vaccine advertisements.

(Reporting by Tina Bellon in New York
Editing by Bill Berkrot)

More News
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.